Hepatocyte growth factor improves the survival of rats with pulmonary arterial hypertension via the amelioration of pulmonary hemodynamics

International Journal of Molecular Medicine

Volumn 27, Issue 4, 2011, Pages 497-502

  Hiramine, Kiyohisa ^a   Sata, Naoyuki ^a   Ido, Akio ^a   Kamimura, Ryozo ^b   Setoyama, Kentaro ^b   Arai, Kou ^b   Nuruki, Norihito ^a   Tanaka, Yasuhiro ^a   Uto, Hirofumi ^a   Tsubouchi, Hirohito ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Hepatocyte growth factor; Monocrotaline; Platelet derived growth factor; Pulmonary arterial hypertension; Pulmonary arterial pressure

Indexed keywords

MONOCROTALINE; PLATELET DERIVED GROWTH FACTOR; RECOMBINANT SCATTER FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; CELL INFILTRATION; CONTINUOUS INFUSION; CONTROLLED STUDY; INFLAMMATORY CELL; LUNG ARTERY PRESSURE; LUNG BLOOD VESSEL; LUNG HEMODYNAMICS; MALE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; PULMONARY ARTERY STENOSIS; PULMONARY HYPERTENSION; RAT; SINGLE DRUG DOSE; SURVIVAL TIME; SYSTOLIC BLOOD PRESSURE;

6-KETOPROSTAGLANDIN F1 ALPHA; ANIMALS; BLOOD PRESSURE; C-REACTIVE PROTEIN; CONSTRICTION, PATHOLOGIC; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HEMODYNAMICS; HEPATOCYTE GROWTH FACTOR; HUMANS; HYPERTENSION, PULMONARY; MALE; MONOCROTALINE; PLATELET-DERIVED GROWTH FACTOR; PULMONARY ARTERY; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; SURVIVAL ANALYSIS;

EID: 79952224980     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.616     Document Type: Article

References (42)

1. Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H and Gaine S: Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 43 (12 Suppl. S): 40S-47S, 2004.
2. Sitbon O, Humbert M, Nunes H, Parent F, Garcia G, Hervé P, Rainisio M and Simonneau G: Long-term intravenous epoprostenol in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 40: 780-788, 2002. (Pubitemid 34925627)
3. Barst RJ, McGoon M, McLaughlin V, Tapson V, Rich S, Rubin L, Wasserman K, Oudiz R, Shapiro S, Robbins IM, Channick R, Badesch D, Rayburn BK, Flinchbaugh R, Sigman J, Arneson C and Jeffs R: Beraprost Study Group: Beraprost therapy for pulmonary arterial hypertension. J Am Coll Cardiol 41: 2119-2125, 2003. (Pubitemid 36724255)
4. Humbert M, Segal ES, Kiely DG, Carlsen J, Schwierin B and Hoeper MM: Results of European post-marketing surveillance of bosentan in pulmonary hypertension. Eur Respir J 30: 338-344, 2007. (Pubitemid 47194187)
5. Galiè N, Beghetti M, Gatzoulis MA, Granton J, Berger RM, Lauer A, Chiossi E and Landzberg M; Bosentan Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) Investigators: Besentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation 114: 48-54, 2006.
6. Croom KF and Curran MP: Sildenafil: a review of its use in pulmonary arterial hypertension. Drugs 68: 383-397, 2008. (Pubitemid 351227349)
7. Humbert M, Sitbon O and Simonneau G: Treatment of pulmonary arterial hypertension. New Engl J Med 351: 1425-1436, 2004.
8. Channick RN, Simonneau G, Sitbon O, Robbins IM, Frost A, Tapson VF, Badesch DB, Roux S, Rainisio M, Bodin F and Rubin LJ: Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomized placebo-controlled study. Lancet 358: 1119-1123, 2001. (Pubitemid 32971843)
9. Gohda E, Tsubouchi H, Nakayama H, Hirono S, Takahashi K, Koura M, Hashimoto S and Daikuhara Y: Human hepatocyte growth factor in plasma from patients with fulminant hepatic failure. Exp Cell Res 166: 139-150, 1986. (Pubitemid 16030464)
10. Gohda E, Tsubouchi H, Nakayama H, Hirono S, Sakiyama O, Takahashi K, Miyazaki H, Hashimoto S and Daikuhara Y: Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 81: 414-419, 1988. (Pubitemid 18075233)
11. Igawa T, Kanda S, Kanetake H, Saitoh Y, Ichihara A and Tomita Y: Hepatocyte growth factor is a potent mitogen for cultured rabbit renal tubular epithelial cells. Biochem Biophys Res Commun 174: 831-838, 1991.
12. Tahara Y, Ido A, Yamamoto S, Miyata Y, Uto H, Hori T, Hayashi K and Tsubouchi H: Hepatocyte growth factor facilitates colonic mucosal repair in experimental ulcerative colitis in rats. J Pharmacol Exp Ther 307: 146-151, 2003. (Pubitemid 37151900)
13. Nakamura T, Mizuno S, Matsumoto K, Sawa Y, Matsuda H and Nakamura T: Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J Clin Invest 106: 1511-1519, 2000. (Pubitemid 32038589)
14. Ido A, Numata M, Kodama M and Tsubouchi H: Mucosal repair and growth factors: recombinant human hepatocyte growth factor as an innovative therapy for inflammatory bowel disease. J Gastroenterol 40: 925-931, 2005. (Pubitemid 41662515)
15. Kusumoto K, Ido A, Moriuchi A, Katsura T, Kim ID, Takahama Y, Numata M, Kodama M, Hasuike S, Nagata K, Uto H, Inui K and Tsubouchi H: Repeated intravenous injection of recombinant human hepatocyte growth factor ameliorates liver cirrhosis but causes albuminuria in rats. Int J Mol Med 17: 503-509, 2006.
16. Homsi E, Janino P, Amano M, Saraiva and Camara NO: Endogenous hepatocyte growth factor attenuates inflammatory response in glycerol-induced acute kidney injury. Am J Nephrol 29: 283-291, 2009.
17. Yanagita K, Matsumoto K, Sekiguchi K, Ishibashi H, Niho Y and Nakamura T: Hepatocyte growth factor may act as a pulmotorophic factor on lung regeneration after acute lung injury. J Biol Chem 268: 21212-21217, 1993. (Pubitemid 23292309)
18. Yamada T, Hisanaga M, Nakajima Y, Mizuno S, Matsumoto K, Nakamura T and Nakano H: Enhanced expression of hepatocyte growth factor by pulmonary ischemia-reperfusion injury in the rat. Am J Respir Crit Care Med 162: 707-715, 2000. (Pubitemid 30647223)
19. Marchand-Adam S, Fabre A, Mailleux AA, Marchai J, Quesnel C, Kataoka H, Aubier M, Dehoux M, Soler P and Crestani B: Defect of hepatocyte growth factor secretion by fibroblasts in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 168: 1156-1161, 2003. (Pubitemid 37421832)
20. Plantier L, Marchand-Adam S, Marchai-Sommé J Lesèche G, Fournier M, Dehoux M, Aubier M and Crestani B: Defect of hepatocyte growth factor production by fibroblasts in human pulmonary emphysema. Am J Physiol Lung Cell Mol Physiol 288: L641-L647, 2005. (Pubitemid 40404131)
21. Yaekashiwa M, Nakayama S, Ohnuma K, Sakai T, Abe T, Satoh K, Matsumoto K, Nakamura T, Takahashi T and Nukiwa T: Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury incued by bleomycin. A morphologic study. Am J Respir Crit Care Med 156: 1937-1944, 1997.
22. Watanabe M, Ebina M, Orson FM, Nakamura A, Kubota K, Koinuma D, Akiyama K, Maemondo M, Okouchi S, Tahara M, Matsumoto K, Nakamura T and Nukiwa T: Hepatocyte growth factor gene transfer to alveolar septa for effective suppression of lung fibrosis. Mol Ther 12: 58-67, 2005. (Pubitemid 40862357)
23. Shigemura N, Sawa Y, Mizuno S, Ono M, Ohta M, Nakamura T, Kaneda Y and Matsuda H: Amelioration of pulmonary emphysema by in vivo gene transfection with hepatocyte growth factor in rats. Circulation 111: 1407-1414, 2005. (Pubitemid 40396807)
24. Gazdhar A, Fachinger P, van Leer C, Pierog J, Gugger M, Friis R, Schmid RA and Geiser T: Gene transfer of hepatocyte growth factor by electroporation induces bleomycin-induced lung fibrosis. Am J Physiol Lung Cell Mol Physiol 292: L529-L536, 2007.
25. Ono M, Sawa Y, Mizuno S, Fukushima N, Ichikawa H, Bessho K, Nakamura T and Matsuda H: Hepatocyte growth factor suppresses vascular medial hyperplasia and matrix accumulation in advanced pulmonary hypertension of rats. Circulation 110: 2896-2902, 2004. (Pubitemid 39473615)
26. Ono M, Sawa Y, Fukushima N, Suhara H, Nakamura T, Yokoyama C, Tanabe T and Matsuda T: Gene transfer of hepatocyte growth factor with prostacyclin synthase in severe pulmonary hypertension of rats. Eur J Cardiothorac Surg 26: 1092-1097, 2004. (Pubitemid 39487453)
27. Ishii T, Sato M, Sudo K, Suzuki M, Nakai H, Hishida T, Niwa T, Umezu K and Yuasa S: Hepatocyte growth factor stimulates liver regeneration and elevates blood protein level in normal and partially hepatectomized rats. J Biochem 117: 1105-1112, 1995.
28. Hasuike S, Ido A, Uto H, Moriuchi A, Tahara Y, Numata M, Nagata K, Hori T, Hayashi K and Tsubouchi H: Hepatocyte growth factor accelerates the proliferation of hepatic oval cells and possibly promotes the differentiation in a 2-acethyamin-ofluorene/partial hepatectomy model in rats. J Gastroenterol Hepatol 20: 1753-1761, 2005. (Pubitemid 43961084)
29. Sato M, Kakubari M, Kawamura M, Sugimoto J, Matsumoto K and Ishii T: The decrease in total collagen fibers in the liver by hepatocyte growth factor after formation of cirrhosis induced by thioacetamide. Biochem Pharmacol 59: 681-690, 2000. (Pubitemid 30085450)
30. Numata M, Ido A, Moriuchi A, Kim ID, Tahara Y, Yamamoto S, Hasuike S, Nagata K, Miyata Y, Uto H and Tsubouchi H: Hepatocyte growth factor facilitates the repair of large colonic ulcers in 2,4,6-trinitrobenzene sulfonic acid-induced colitis in rats. Inflamm Bowel Dis 11: 551-558, 2005. (Pubitemid 40826342)
31. Ido A and Tsubouchi H: Translational research to identify clinical applications of hepatocyte growth factor. Hepatol Res 39: 739-747, 2009.
32. Yang R, Bunting S, Ko A, Schwall R and Jin H: Hemodynamic effects of scatter factor in conscious rats. J Cardiovasc Pharmacol 30: 294-301, 1997. (Pubitemid 28006842)
33. Ido A, Moriuchi A, Kim ID, Numata M, Nagata-Tsubouchi Y, Hasuike S, Uto H and Tsubouchi H: Pharmacokinetic study of recombinant human hepatocyte growth factor administered in a bolus intravenously or via portal vein. Hepatol Res 30: 175-181, 2004. (Pubitemid 39654749)
34. Dorfmuller P, Perros F, Balabanian K and Humbert M: Inflammation in pulmonary arterial hypertension. Eur Respir J 22: 358-363, 2003. (Pubitemid 36987011)
35. Farber HW and Loscalzo J: Pulmonary arterial hypertension: New Engl J Med 351: 1655-1665, 2004.
36. Ushio-Fukai M, Griendling KK, Becker PL, Hilenski L, Halleran S and Alexander RW: Epidermal growth factor receptor transactivation by angiotensin II receptor requires reactive oxygen species in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 21: 489-495, 2001. (Pubitemid 32323378)
37. Xin X, Johnson AD, Scott-Burden T, Engler D and Casscells W: The predominant form of fibroblast growth factor receptor expressed by proliferating human arterial smooth muscle cells in culture in type I. Biochem Biophys Res Commun 204: 557-564, 1994. (Pubitemid 24343956)
38. Yu Y, Sweeney M, Zhang S, Platoshyn O, Landsberg J, Rothman A and Yuan JX: PDGF stimulates pulmonary vascular smooth muscle cell proliferation by upregulating TRPC6 expression. Am J Physiol Cell Physiol 284: C316-C330, 2003. (Pubitemid 36120070)
39. Schermuly RT, Dony E, Ghofrani HA, Pullamsetti S, Savai R, Roth M, Sydykov A, Lai YJ, Weissmann N, Seeger W and Grimminger F: Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 115: 2811-2821, 2005. (Pubitemid 41434408)
40. Chhina MK, Nargues W, Grant GM and Nathan SD: Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension. Future Cardiol 6: 19-35, 2010.
41. Sakao S, Tatsumi K and Voelkel NF: Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation. Respir Res 10: 95, 2009.
42. Perros F, Dorfmüller P and Humbert M: Current insights on the pathogenesis of pulmonary arterial hypertension. Semin Respir Crit Care Med 26: 355-364, 2005. (Pubitemid 41266491)